Sexual Function Following High Energy Microwave Thermotherapy: Results of a Randomized Controlled Study Comparing Transurethral Microwave Thermotherapy to Transurethral Prostatic Resection

Francisca, E.A.E.; d’Ancona, Frank; Meuleman, E.J.H.; Debruyne, F.M.J.; Rosette, Jean J.M.C.H. de la

doi:10.1016/s0022-5347(01)61930-x

Cited by 51 publications

(34 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Reoperation rates for TUMT were derived from two RCTs. 86,87 However, the AHCPR guideline is over 10 years old and its authors admit that very few studies reported symptom scores and that those that did used many different methods. 84 Although this limitation is allowed for to some extent in the wide confidence interval (CI) for this estimate (see Accounting for uncertainty in Chapter 10, p.112), the relationship between degree of symptom improvement and probability of retreatment is unclear.…”

Section: Effectivenessmentioning

confidence: 99%

Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement

Lourenço

Armstrong²,

N’Dow³

et al. 2008

Health Technol Assess

116

View full text Add to dashboard Cite

Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Lourenco, T.; Armstrong, N.; N'Dow, J.; Nabi, G.; Deverill, M.; Pickard, R.; Vale, L.; MacLennan, G.; Fraser, C.; McClinton, S.; Wong, S.; Coutts, A.; Mowatt, G.; Grant, A. Published in: Health Technology Assessment Publication date: 2008 Document VersionPublisher's PDF, also known as Version of record Link to publication in Discovery Research Portal Citation for published version (APA):Lourenco, T., Armstrong, N., N'Dow, J., Nabi, G., Deverill, M., Pickard, R., ... Grant, A. (2008). Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technology Assessment, 12(35). General rightsCopyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.• Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.• You may not further distribute the material or use it for any profit-making activity or commercial gain.• You may freely distribute the URL identifying the publication in the public portal. Take down policyIf you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 12. May. 2018 Health Technology Assessment 2008; Vol. 12: No. 35 Health Technology Assessment NIHR HTA Programme www.hta.ac.uk November 2008 Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement How to obtain copies of this and other HTA Programme reports. An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable CD-ROM is also available (see below).Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £3...

show abstract

Section: Effectivenessmentioning

confidence: 99%

Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement

Lourenço

Armstrong²,

N’Dow³

et al. 2008

Health Technol Assess

116

View full text Add to dashboard Cite

show abstract

“…First, as the symptoms become less bothersome, patients may feel less 'disabled' by their urinary symptoms and may thus be better able to enjoy other facets of life Sexual effects of medical therapy for benign prostatic hyperplasia DJ Carbone and S Hodges without feeling inhibited or limited. 55 Alternatively, inhibition of the a 1 -and a 1D -adrenoreceptor subtypes that predominate in cavernosal smooth muscle should facilitate erection. 56 The mechanism by which a-blockers affect the erectogenic response is via relaxation of the smooth muscle in the penile arteries or the corpora cavernosum, thus improving the inflow of blood.…”

Section: Medical Therapy For Bphmentioning

confidence: 99%

Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life

Carbone

Hodges

2003

Int J Impot Res

View full text Add to dashboard Cite

Therapies for benign prostatic hyperplasia (BPH) may either improve or exacerbate sexual function with an ensuing impact on quality of life. Here we review a total of 73 papers on medical therapies for BPH with a focus on the effects of different pharmacological agents on sexual function. For example, certain a 1 -adrenergic receptor blockers may improve erectile function; however, ejaculatory dysfunction with one of these agents, tamsulosin, occurs at a rate of 4-18%, rising to 30% with long-term use. In addition, treatment with the 5a-reductase inhibitor finasteride is associated with problems of ejaculation (2.1-7.7%), erection (4.9-15.8%), and libido (3.1-5.4%). Such significant and undesirable complications in relation to sexual function produce a welldocumented negative impact on quality of life. Thus, optimal treatment for men with BPH requires the use of agents that demonstrate efficacy and safety with fewer sexual side effects.

show abstract

“…Although ejaculatory pain in the general male population is considered to be 1%, 1 it is presented a serious problem for 88-91% of men who experience it. 2,3 It can be caused by prostatectomy, 4,5 a history of prostatitis, 6 pelvic radiation, 7,8 lower urinary tract symptoms (LUTS) diagnosed with clinical benign prostatic hyperplasia (BPH), 9,10 chronic pelvic pain disorder, 11 and neuroleptics. [12][13][14][15][16][17][18] On the other hand, PE as a sole entity is rare, and its etiology often remains unknown.…”

Section: Introductionmentioning

confidence: 99%

Safety and efficacy of tamsulosin in the treatment of painful ejaculation: a randomized, double-blind, placebo-controlled study

Safarinejad¹

2006

Int J Impot Res

View full text Add to dashboard Cite

Sexual Function Following High Energy Microwave Thermotherapy: Results of a Randomized Controlled Study Comparing Transurethral Microwave Thermotherapy to Transurethral Prostatic Resection

Cited by 51 publications

References 27 publications

Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement

Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement

Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life

Safety and efficacy of tamsulosin in the treatment of painful ejaculation: a randomized, double-blind, placebo-controlled study

Contact Info

Product

Resources

About